Farrell G - Search Results

1

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J; Cirrhosis Asian Lamivudine Multicentre Study Group. Liaw YF, et al. Among authors: farrell g. N Engl J Med. 2004 Oct 7;351(15):1521-31. doi: 10.1056/NEJMoa033364. N Engl J Med. 2004. PMID: 15470215 Free article. Clinical Trial.

2

Towards consensus on the control of chronic hepatitis B and hepatitis C in the Asia-Pacific region.

Farrell GC, Liaw YF. Farrell GC, et al. J Gastroenterol Hepatol. 2000 May;15 Suppl:E1-2. doi: 10.1046/j.1440-1746.2000.0155(suppl.)0e1.x. J Gastroenterol Hepatol. 2000. PMID: 10921372 No abstract available.

3

JGH and Asia-Pacific consensus on prevention and management of gastrointestinal and liver diseases.

Farrell G, Liaw YF, McCaughan G. Farrell G, et al. J Gastroenterol Hepatol. 2000 Aug;15(8):815-8. doi: 10.1046/j.1440-1746.2000.02322.x. J Gastroenterol Hepatol. 2000. PMID: 11022819 Review. No abstract available.

4

Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.

Hui JM, George J, Liddle C, Lin R, Samarasinghe D, Crewe E, Farrell GC. Hui JM, et al. Am J Gastroenterol. 2002 Apr;97(4):1003-9. doi: 10.1111/j.1572-0241.2002.05621.x. Am J Gastroenterol. 2002. PMID: 12003380

5

Management of chronic hepatitis C virus infection: a new era of disease control.

Teoh NC, Farrell GC. Teoh NC, et al. Among authors: farrell gc. Intern Med J. 2004 Jun;34(6):324-37. doi: 10.1111/j.1445-5994.2004.00615.x. Intern Med J. 2004. PMID: 15228394 Review.

6

Hepatitis B e antigen seroconversion: effects of lamivudine alone or in combination with interferon alpha.

Farrell G. Farrell G. J Med Virol. 2000 Jul;61(3):374-9. doi: 10.1002/1096-9071(200007)61:3<374::aid-jmv16>3.0.co;2-7. J Med Virol. 2000. PMID: 10861649 Review.

7

Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.

Coverdale SA, Khan MH, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Liddle C, Kench JG, Crewe E, Farrell GC. Coverdale SA, et al. Among authors: farrell gc. Am J Gastroenterol. 2004 Apr;99(4):636-44. doi: 10.1111/j.1572-0241.2004.04085.x. Am J Gastroenterol. 2004. PMID: 15089895 Review.

8

Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.

Bandara P, George J, McCaughan G, Naidoo D, Lux O, Salonikas C, Kench J, Byth K, Farrell GC. Bandara P, et al. Among authors: farrell gc. Liver Int. 2005 Jun;25(3):518-26. doi: 10.1111/j.1478-3231.2005.01049.x. Liver Int. 2005. PMID: 15910488

9

Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.

Kumar D, Farrell GC, Kench J, George J. Kumar D, et al. J Gastroenterol Hepatol. 2005 Sep;20(9):1395-400. doi: 10.1111/j.1440-1746.2005.04007.x. J Gastroenterol Hepatol. 2005. PMID: 16105127

10

Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.

Coverdale SA, Samarasinghe DA, Lin R, Kench J, Byth K, Khan MH, Crewe E, Liddle C, George J, Farrell GC. Coverdale SA, et al. Am J Gastroenterol. 2003 Jun;98(6):1384-90. doi: 10.1111/j.1572-0241.2003.07468.x. Am J Gastroenterol. 2003. PMID: 12818285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters